Ideenat 150mg Tablet

PRODUCT INTRODUCTION

Ideenat 150mg Tablet is a medication primarily used in the treatment of certain types of cancers. It belongs to a class of medications known as tyrosine kinase inhibitors. The active ingredient in Ideenat tablets is Imatinib Mesylate, which works by blocking the action of abnormal protein signals that promote the growth of cancer cells.

This medication is typically prescribed by healthcare professionals for the management of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other conditions where abnormal cell growth is a concern. Ideenat tablets are usually taken orally, with or without food, as directed by a doctor. It is crucial to follow the prescribed dosage and schedule to achieve the best possible outcome.

USES OF Ideenat 150mg Tablet

Chronic Myeloid Leukemia (CML): Ideenat 150mg Tablet is widely used in the treatment of chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow. It helps in controlling the growth of cancerous cells, thereby preventing the progression of the disease and improving survival rates. Ideenat is often prescribed as a first-line therapy for newly diagnosed CML patients and also for those who have not responded well to other treatments.

Gastrointestinal Stromal Tumors (GISTs): Ideenat tablets are also effective in the management of gastrointestinal stromal tumors, which are rare tumors that develop in the digestive tract. By inhibiting the abnormal protein signals responsible for tumor growth, Ideenat helps in shrinking the size of GISTs, relieving symptoms, and improving overall quality of life for patients.

BENEFITS OF Ideenat 150mg Tablet

Effective Cancer Treatment: Ideenat has shown remarkable efficacy in the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Clinical studies have demonstrated significant improvements in disease control, prolongation of survival, and reduction in the risk of disease progression when Ideenat is used as part of the treatment regimen.

Improved Quality of Life: By effectively controlling the growth of cancer cells, Ideenat helps in alleviating symptoms associated with CML and GISTs, such as fatigue, abdominal pain, and difficulty swallowing. This leads to an overall improvement in the quality of life for patients, allowing them to carry out their daily activities with greater comfort and ease.

Convenient Oral Administration: Ideenat tablets are taken orally, making them convenient and easy to administer. Patients can take their prescribed dose at home without the need for frequent hospital visits or invasive procedures, enhancing treatment adherence and compliance.

SIDE EFFECTS OF Ideenat 150mg Tablet

While Ideenat is generally well-tolerated by most patients, like any medication, it may cause certain side effects. Common side effects associated with Ideenat 150mg Tablet include:

Nausea and Vomiting: Some patients may experience mild to moderate nausea and vomiting, especially during the initial stages of treatment. These symptoms can often be managed with anti-nausea medications and usually improve over time.

Fatigue: Ideenat may cause fatigue and weakness in some patients. It is essential to get an adequate amount of rest and engage in light physical activity to combat fatigue while undergoing treatment.

Fluid Retention: Some individuals may experience fluid retention, leading to swelling of the hands, feet, or ankles. Monitoring fluid intake and following a low-sodium diet can help reduce this side effect.

Muscle Cramps: Ideenat may occasionally cause muscle cramps or spasms, which can be uncomfortable but are usually temporary. Gentle stretching exercises and staying hydrated may help alleviate muscle cramps.

Skin Rash: A skin rash or itching may occur as a reaction to Ideenat. It is essential to inform your healthcare provider if you develop any skin-related symptoms, as they can provide guidance on appropriate management.

Changes in Blood Counts: Ideenat can affect blood cell counts, leading to a decrease in white blood cells, red blood cells, or platelets. Regular blood tests are necessary to monitor these levels, and adjustments to the treatment regimen may be made if needed.

References